1-20 of 115
Anna Azvolinsky, PhD
Close
Sort by
News

Hematologic Toxicities Affect Efficacy Outcomes of BCMA CAR T-Cell Therapy in Multiple Myeloma, Study Shows

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
Mid-November 2025
View News titled, Hematologic Toxicities Affect Efficacy Outcomes of BCMA CAR T-Cell Therapy in Multiple Myeloma, Study Shows
News

Immunoglobulin Replacement Therapy Not Associated With Reduced Risk of Infection-Related Hospitalizations Among Patients with CLL

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
November 2025
View News titled, Immunoglobulin Replacement Therapy Not Associated With Reduced Risk of Infection-Related Hospitalizations Among Patients with CLL
News

Talquetamab Bridging Therapy Enables Transition to BCMA CAR-T for Patients With High-Risk Myeloma

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
October 2025
View News titled, Talquetamab Bridging Therapy Enables Transition to BCMA CAR-T for Patients With High-Risk Myeloma
News

Quadruplet Induction Therapy for MM Achieves High Rate of MRD Negativity in MIDAS Trial

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
October 2025
View News titled, Quadruplet Induction Therapy for MM Achieves High Rate of MRD Negativity in MIDAS Trial
News

Study Identifies CD38 Mutations That Confer Resistance to CD38-Targeting Antibodies in Patients with Multiple Myeloma

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
September 2025
View News titled, Study Identifies CD38 Mutations That Confer Resistance to CD38-Targeting Antibodies in Patients with Multiple Myeloma
News

Keeping Up With GLP-1s: What Hematologists Need to Know

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
September 2025
View News titled, Keeping Up With GLP-1s: What Hematologists Need to Know
News

Cytokine-Secreting CAR T-Cell Candidate Therapy Shows Preliminary Efficacy in Patients With Lymphoma

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
August 2025
View News titled, Cytokine-Secreting CAR T-Cell Candidate Therapy Shows Preliminary Efficacy in Patients With Lymphoma
News

Absolute Level of FLC in Patients With AL Amyloidosis Treated with Daratumumab- Based Regimens Not Prognostic

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
August 2025
View News titled, Absolute Level of FLC in Patients With AL Amyloidosis Treated with Daratumumab- Based Regimens Not Prognostic
News

Five-Year Results of SEQUOIA Trial Show Maintenance of Benefit for Patients With Del(17p) Treatment-Naïve CLL Treated With Zanubrutinib

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, Five-Year Results of SEQUOIA Trial Show Maintenance of Benefit for Patients With Del(17p) Treatment-Naïve CLL Treated With Zanubrutinib
News

Systematic Review Identifies Sensitive Rapid Point-of-Care ADAMTS13 Assay to Reliably Diagnose TTP

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Systematic Review Identifies Sensitive Rapid Point-of-Care ADAMTS13 Assay to Reliably Diagnose TTP
News

Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Oral Thrombopoietin Receptor Agonist Eltrombopag Also Functions as Iron Chelator, Study Finds
News

Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Large Database Study Maps Treatment Use Among Elderly, Veteran Patients With DLBCL
News

Results Detail Comparison of Patients With R/R CLL/SLL in Liso-Cel TRANSCEND CLL 004 Trial With Real-World Cohort

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, Results Detail Comparison of Patients With R/R CLL/SLL in Liso-Cel TRANSCEND CLL 004 Trial With Real-World Cohort
News

MRD Negativity Associated with PFS and OS Benefit in DREAMM-8 Multiple Myeloma Trial

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
July 2025
View News titled, MRD Negativity Associated with PFS and OS Benefit in DREAMM-8 Multiple Myeloma Trial
News

Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
June 2025
View News titled, Large Study Clarifies Risk of Thrombosis Associated With Protein S Deficiency
News

Venetoclax Plus Decitabine Shows Similar Efficacy to Intensive Chemotherapy as Front- Line Therapy for Young, Fit Patients With AML

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
May 2025
View News titled, Venetoclax Plus Decitabine Shows Similar Efficacy to Intensive Chemotherapy as Front- Line Therapy for Young, Fit Patients With AML
News

Responses to BCMA CAR T Cells Not Durable in Patients with MM with CNS Involvement

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
April 2025
View News titled, Responses to BCMA CAR T Cells Not Durable in Patients with MM with CNS Involvement
News

Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
April 2025
View News titled, Non-Transplant Salvage Therapy Safe for Pediatric, Adolescent Patients with R/R cHL
News

Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
March 2025
View News titled, Study Maps Clinical Evolution of Fanconi Anemia Using Large Patient Registry
News

Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma

Free
Anna Azvolinsky, PhD
Published: 2025
Abstract
March 2025
View News titled, Mass Spectrometry an Effective Method to Detect Measurable Residual Disease in Multiple Myeloma